Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterise the pharmacokinetic profiles of non-nucleoside
analog reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs), and the
influence of the individual characteristics on the pharmacokinetic parameters in the Spanish
population of HIV-infected subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Germans Trias i Pujol Hospital
Collaborators:
Fundacio Lluita Contra la SIDA Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia